## CEG: Constellation Energy Corporatio - XLU: Utilities

### Executive Summary

No thesis match: MRS_10 -2.6% below STRENGTH zone (3.0-6.0%); PEG 3.63 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($305.07)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. NRC Renews Operating Licenses for Clinton & Dresden; Constellation Investing $370 Million in State-of-the-Art Upgrades to Keep These Illinois Nuclear Facilities Online, Meet Rising Power Demand and Support Economic Growth**
- Source: Constellation Energy | 20251216T190943 | Bullish | Relevance: 100%
- The NRC has renewed operating licenses for Constellation's Clinton and Dresden Clean Energy Centers for 20 years, preserving over 2,200 jobs and generating $8.1 billion in tax revenues. Constellation is investing more than $370 million in state-of-the-art upgrades to these facilities, ensuring their continued safety, reliability, and efficiency. This renewal supports Illinois's clean energy future and economic growth by guaranteeing a continued supply of carbon-free power for decades.

**2. Constellation Energy Corporation (CEG) Receives a Buy from Bank of America Securities**
- Source: The Globe and Mail | 20251216T115504 | Bullish | Relevance: 100%
- Bank of America Securities analyst Ross Fowler maintained a Buy rating for Constellation Energy Corporation (CEG) with a price target of $407.00. Fowler has a 5.4% average return and 58.12% success rate on recommended stocks. This comes as Constellation Energy reported strong Q3 earnings with $7.18 billion in revenue and $930 million in net profit.

**3. Evaluating Constellation Energy (CEG) Stock's Actual Performance**
- Source: Finviz | 20251216T050745 | Bullish | Relevance: 100%
- Constellation Energy (CEG) has demonstrated strong financial performance since its 2022 spinoff from Exelon, driven by a resurgence in demand for nuclear energy. The company boasts impressive total returns that have significantly outpaced the S&P 500, fueled by strategic power purchase agreements with major tech companies like Microsoft and Meta. Its acquisition of Calpine is set to further boost earnings, positioning CEG for continued growth.

**4. Constellation Energy (CEG) Stock Today: Calpine Deal Nears Close as Nuclear Dataâ€‘Center Contracts Shape 2026 Outlook (Dec. 15, 2025)**
- Source: ts2.tech | 20251215T192317 | Bullish | Relevance: 100%
- Constellation Energy (CEG) is in focus due to its nearing Calpine acquisition, federal support for nuclear power, and momentum in "24/7 carbon-free" power contracts for AI data centers. The article details recent news including a positive Zacks/Nasdaq feature, government initiatives for nuclear-powered data centers, and an "Energy Deal of the Year" award for its Microsoft PPA. The strategic importance of the Calpine deal and long-term nuclear contracts with major tech companies like Microsoft and Meta are highlighted as key drivers for Constellation's future earnings.

**5. Constellation Energy Clears PJM Capacity Auction**
- Source: TipRanks | 20251217T225111 | Bullish | Relevance: 100%
- Constellation Energy Corporation announced that all its power plants in the PJM market successfully cleared the capacity auction for the 2027-2028 planning year, including both nuclear and fossil-based capacities. This ensures continued monetization through capacity revenues and alignment with Production Tax Credit calculations, effective June 1, 2027. Spark, an AI Analyst, rates CEG as "Outperform" due to strong earnings call performance and positive technical indicators, despite some valuation and financial challenges.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $420 | $385 | +9% |
| 2025-12-16 | JP Morgan | $410 | $422 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Buy |
| 2025-12-16 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.13M) |
| Sells | 1 ($4.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.1%)
- Capital Internationa: 8.4% (-7.3%)
- Blackrock Inc.: 7.2% (+0.8%)
- State Street Corpora: 5.8% (+0.3%)
- FMR, LLC: 4.2% (-6.8%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-6.3% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $4.5M in recent transactions.
3. Valuation stretched: PEG 3.6x requires aggressive growth execution.
4. Near-term weakness: 6.5% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.63 signals overvaluation risk, limited margin of safety. Balance sheet: $1.5B free cash flow. Insider selling cluster ($4.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $106.5B |
| Beta | 1.14 |
| 52W Range | $161.35 - $412.70 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.63 |
| Forward P/E | 30.1 |
| Current P/E | 36.7 |
| YoY Growth | 21.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.7% to -2.6% (-6.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.11x) but short-term weakness (below SMA20). MACD histogram bearish (-0.83), momentum weakening. RSI neutral at 43. OFD pattern: -MTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.58% (CS: 14) | Weak |
| RSI_14 | 43.0 | Neutral |
| MACD Histogram | -0.83 | Bearish |
| vs SMA20 | 0.953x | Below |
| vs SMA50 | 0.935x | Below |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $340.97
- **Stop Loss:** $305.07 (10.5% risk)
- **Target:** $376.87 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 25
- **Position Value:** $8,524.25
- **Portfolio %:** 8.52%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 90% | L2 100% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-17 (Est: $2.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.12 | $3.04 | -2.6% |
| 2025Q2 | $1.83 | $1.91 | +4.2% |
| 2025Q1 | $2.21 | $2.14 | -3.1% |
| 2024Q4 | $2.14 | $2.44 | +14.1% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*